Introduction
Higher eukaryotic promoters and enhancers are generally complex in structure, consisting of multiple sequence motifs that serve as binding sites for various transcription factors (Tjian and Maniatis, 1994) . Often, a binding site is recognized by different members of a family of regulatory proteins that have identical or overlapping DNA-binding specificities. For example, octamer-binding sites are recognized by Oct-1, Oct-2, Oct-3 or Oct-6 (Scholer, 1991 Winoto, 1992), and the GATA motif by GATA-1, GATA-2, GATA-3, GATA-4 or GATA-6 (Simon, 1995) . When two or more members of a regulatory protein family occur in the same cell type, it becomes difficult to determine which member(s) controls transcription of different target genes in vivo.
The regulatory activity of a transcription factor is influenced both by the context of the binding site in the promoter or enhancer and by cell type-specific factors and co-activators (Roberts and Green, 1995) . Therefore, it is important to study the activity of the factor in the context of the appropriate cell type. A common approach used to distinguish the regulatory activities of related transcription factors involves overexpression of individual family members in the appropriate cell type. However, analyzing the effects of a particular transcription factor on its target regulatory region in this manner is confounded by the presence of its endogenous counterpart and related family members. An alternative approach involves ectopic expression of individual family members. This approach has significant limitations since the cell types used may not express the other relevant cell type-specific transcription factors, and thus their contribution would go unaccounted for. For a complex promoter or enhancer, it is exceedingly difficult to reconstitute the appropriate combination and levels of other relevant regulatory proteins in a heterologous cell type. Targeted disruption of genes encoding individual family members represents a powerful means of analyzing their function. However, gene targeting of transcription factors may cause developmental defects resulting in loss of the relevant cell type(s). Even in cases where the appropriate cell type is present, the effects on target genes may be indirect. Also, gene targeting may fail to reveal the regulatory role of a particular family member due to partial or complete redundancies.
In this study, we describe a novel and general approach to analyze individually the regulatory activities of different members of a family of transcription factors in an appropriate cell type using native promoters or enhancers. The approach involves mutating a regulatory site and then rescuing the mutation using altered specificity mutant transcription factors (Figure 1 ). The first step involves a screen for severe binding site mutations that impair recognition by wild-type family members and consequently inactivate the regulatory region in vivo. The second step entails isolation of an altered specificity mutant family member that can bind to the mutant site. A related set of altered specificity family members is then generated by engineering the relevant mutation(s) in each protein. Finally, each altered specificity family member can then be expressed individually in vivo to determine its ability to rescue the function of the mutant regulatory region. This approach allows regulatory functions of individual related transcription factors to be assayed in Fig. 1 . Altered specificity mutants as tools for analyzing functions of related transcription factors. The left panel depicts an octamer elementdependent promoter in a B cell. It is recognized by two different transcription factors, Oct-1 and Oct-2, which have identical DNA-binding properties. A mutation in this octamer element severely impairs the promoter. Right panels depict how altered specificity mutants (asm) Oct-1 or Oct-2, which can bind the mutant octamer sequence, are used to measure their relative abilities to restore function in the presence of their wild-type counterparts.
the correct cell type(s) without the results being obscured by the activities of endogenous wild-type counterparts.
Immunoglobulin (Ig) gene promoters represent the prototypical examples of regulatory elements whose activities appear to be controlled by two related transcription factors with identical DNA-binding specificities. These promoters contain one conserved element, the octamer ATGCAAAT, which is necessary for their activity in B cells (Bergman et al., 1984; Falkner and Zachau, 1984; Mason et al., 1985) . Mutation of this element in the promoter of a rearranged Ig heavy chain transgene reduces expression 20-to 30-fold in lymphoid tissues (Jenuwein and Grosschedl, 1991) . Furthermore, the octamer element activates heterologous promoters preferentially in B cells (Dreyfus et al., 1987; Wirth et al., 1987) . Thus, the octamer element is both necessary and sufficient for the preferential activity of Ig promoters in B cells. Interestingly, the same motif is an important element of the promoters of ubiquitously expressed genes such as the U2 and U6 snRNA genes and the histone H2B gene (LaBella et al., 1988; Murphy et al., 1989) . The ability of the octamer element to promote ubiquitous as well as B cell-specific gene expression was suggested initially to reside in its interaction with two distinct transcription factors, Oct-2 and Oct-1 Staudt et al., 1986) . While they contain related DNAbinding domains with identical recognition specificities, they are structurally quite distinct (reviewed in Herr and Cleary, 1995) . Oct-2 and Oct-1 are members of the POU family of homeodomain proteins. POU proteins contain a 150-160 amino acid bipartite DNA-binding domain which consists of a conserved N-terminal POU-specific domain and a C-terminal POU homeodomain. The ATGC half of the octamer element is recognized by the POU-specific domain, whereas the AAAT half is recognized by the POU homeodomain. The oct-1 gene is expressed in a variety of cell types, whereas oct-2 expression is restricted to cells of the lymphoid and central nervous systems. Their differing distributions led to the proposal that Oct-1 regulates transcription of U snRNA and histone H2B genes, while Oct-2 specifically activates Ig gene transcription (Schaffner, 1989) .
Several studies involving ectopic expression of Oct-2 led to differing conclusions concerning its ability specifically to regulate the activity of Ig gene promoters in B cells (Junker et al., 1990; Tanaka and Herr, 1990; Kemler et al., 1991) . Targeted disruption of the oct-2 gene in mice and in a somatic B cell line have shown that Oct-2 is not essential for transcription of Ig genes (Corcoran et al., 1993; Feldhaus et al., 1993) . However, the gene targeting studies may have failed to reveal Oct-2's role in Ig gene transcription due to partial or complete redundancy with Oct-1. We use altered specificity mutants of Oct-1 and Oct-2 to demonstrate that the two factors are functionally redundant in regulating Ig gene promoters in B cells. The structural basis of redundancy resides in the highly conserved POU domain, since this domain of either protein is sufficient to activate transcription. Interestingly, the potency of these activators from an Ig promoter is influenced by the type of remote enhancer. Oct-1 preferentially stimulates transcription from Ig gene promoters in combination with Ig gene enhancers. These results suggest that Oct-1 may be the critical regulator of Ig gene transcription during B cell development.
Results
Using expression screening for the isolation of altered specificity mutants A widely used method for cloning transcription factors involves screening a bacteriophage λgt11 cDNA expression library with a radiolabeled binding site probe (Singh, 1993) . Since the screen serves as a simple but powerful assay for DNA binding by a large number of distinct recombinant proteins, it seemed possible to use the same approach to isolate altered specificity mutants of transcription factors. In this extension of the original method, the following steps are involved: (i) identification of a mutant binding site that severely reduces recognition by the wild-type transcription factor; (ii) generation of a λgt11 Altered specificity mutants: Oct-1 versus Oct-2
Fig. 2. (A)
Identification of severe mutations in the octamer site. All single base substitutions in the AAAT subsite of the octamer element were made, with the exception of A5T. Each mutant site was radiolabeled and used in a gel-shift assay to measure binding of Oct-2 isoforms and Oct-1 with a WEHI-231 B cell nuclear extract. OCTA denotes the wild-type site. P indicates the lane containing free probe. The positions of protein-DNA complexes formed by Oct-1, Oct-2B and Oct-2A are indicated on the right. Non-specific complexes are indicated with an asterisk (*). Six mutations that reduce the affinity of both proteins Ͼ50-fold are depicted below the sequence. (B) Structure of the Oct-1 POU domain bound to the octamer. Structural representation of the complex was generated using coordinates provided by Klemm et al. (1994) and Insight II software (Biosym Technologies). POU S and POU HD refer to the POU-specific and POU homeodomain respectively. The following residues in the complex are highlighted: Adenine 7 of the octamer (A7) makes specific hydrogen bonds with Asn51 (N51) of the POU HD ; N51 along with Val47 (V47) and Cys50 (C50) of the POU HD were selected for mutagenesis; Asp41 (D41), in the turn between helix 2 and 3 of the POU S domain, is the site of glycine substitution in the Oct-2 altered specificity mutant. (C) Isolation of an altered specificity Oct-2 mutant by expression screening with an A7G mutant probe. The figure shows the results of screening filters generated from platings of the wild-type phage (λOct-2) and an altered specificity (λOct-2 V47R D41G) recombinant phage. OCTA and A7G denote the wild-type and mutant probes respectively. Each probe contains three copies of the relevant sequence. (D) Results of screening filters generated from platings of the wild-type (λOct-2) and λOct-2 V47R N51R recombinant phage.
library expressing mutant forms of the transcription factor; (iii) screening the mutant expression library with the mutant binding site probe; and (iv) characterization of the binding properties of the mutant protein in solution. We demonstrate the utility of this approach with two distinct altered specificity Oct-2 mutants.
In order to identify severe mutations in the octamer site, we performed a systematic single base substitution mutagenesis of the AAAT subsite. All possible single base substitutions in the AAAT subsite (with the exception of A5T) were engineered and tested for their ability to be recognized by Oct-2 and Oct-1 (Figure 2A ). The A5T mutation had been shown previously to reduce affinity only 2-fold (Verrijzer et al., 1992) . The relative affinity of Oct-2 and Oct-1 for these mutant sites versus the wildtype site were also measured by competition analyses using gel-shift assays (data not shown). Six single base mutations were found to reduce the affinity of both proteins Ͼ50-fold (A5G, A5C, A6C, A7T, A7G and A7C). None of the mutations at position 8 were as severe. Any of the six severe mutants were suitable for screening a mutant Oct-2 protein library for a corresponding altered specificity protein. We selected a mutation at A7, because this base makes specific and highly conserved hydrogen bond contacts with the amino acid N51 in the POU homeodomain recognition helix. Of the three possible substitutions of A7, A7G was used as it was the most severe mutation.
To isolate an altered specificity mutant Oct-2 that can recognize the A7G site with higher affinity, three residues in the POU homeodomain recognition helix (Val47, Cys50 and Asn51) were chosen for randomization ( Figure 2B ). We mutated codons for Val47 and Asn51 with the view that in classical homeodomain proteins, amino acids at these positions are in close proximity to the mutated base (Kissinger et al., 1990) . Furthermore, in the case of classical homeodomains, position 9 (corresponding to Cys50) was shown to be a critical determinant of binding specificity (Hanes and Brent, 1989; Treisman et al., 1989) . A library of all possible single amino acid substitutions at these three positions was generated using a λgt11 phage that encoded a β-gal-Oct-2 POU domain fusion protein (see Materials and methods).
Screening of 30 000 clones of the Oct-2 mutant library with the A7G probe resulted in the isolation of two identical recombinant phage. The protein encoded by the mutant phage contained two amino acid substitutions: Val47 to arginine (V47R) in the POU homeodomain and Asp41 to glycine (D41G) in the POU-specific domain (numbering follows that used in Klemm et al., 1994) . The mutant phage is designated λOct-2 V47R D41G, while λOct-2 denotes phage encoding wild-type Oct-2. In filter screening assays, Oct-2 V47R D41G has altered specificity; it binds the A7G site with increased affinity over the wild-type protein and retains high affinity recognition for the wild-type site ( Figure 2C ). Although the D41G mutation was probably generated by the infidelity of Taq polymerase during the PCR-based mutagenesis, it proved to be important for the binding properties of the mutant protein (see below).
As this phase of the study was being completed, Pomerantz and Sharp (1994) reported the isolation of an altered specificity mutant Oct-1 POU domain by screening a plasmid-based expression library. Coincidentally, the Oct-1 mutant POU domain was also isolated in a screen using a mutant A7G octamer. This mutant protein contained two amino acid substitutions, V47R and N51R, both in the POU homeodomain. Note that one of the mutations is shared with the V47R D41G mutant Oct-2 protein described above, and the other is different. The reason that the V47R N51R mutation was not isolated in our screen is because our library was not constructed to contain double mutations in the POU homeodomain. To demonstrate that our method can readily detect different altered specificity mutants, we constructed and screened an Oct-2 mutant phage carrying the V47R N51R mutations ( Figure 2D ). It can be seen that both types of Oct-2 mutant phage (V47R D41G and V47R N51R) give signals comparable with the A7G probe.
Binding properties of Oct-2 altered specificity mutants To permit a direct comparison of the two types of altered specificity mutants that can recognize the A7G site with increased affinity as compared with wild-type, and to test if the D41G mutation was playing a role in alteration of specificity, the single and double mutations were engineered in the context of a full-length Oct-2 cDNA. It should be noted that the binding properties of the V47R N51R mutant protein, as reported by Pomerantz and Sharp (1994) , were analyzed using a bacterially expressed protein A-Oct-1 POU domain fusion and not a native protein.
Radiolabeled full-length Oct-2 proteins were produced by in vitro transcription and translation. The proteins were then tested for their ability to bind a wild-type octamer and the A7G mutant site by gel-shift assays ( Figure 3A ). Under these conditions, wild-type Oct-2 protein bound to the octamer with Ͼ100-fold higher affinity (K d ϭ 2.5 nM) than to the A7G mutant site. The V47R mutant protein 7108 exhibited 1.5-fold reduced affinity for the wild-type octamer, but 2.5-fold increased affinity for the A7G site, as compared with the wild-type protein. All relative affinity and dissociation constant (K d ) measurements are based on gel-shift assays employing equal amounts of radiolabeled proteins (see Materials and methods). Importantly, the V47R D41G double mutant protein bound the octamer with 2-fold reduced affinity and the A7G site with 4-fold higher affinity (K d ϭ 90 nM) compared with wild-type Oct-2. Thus the D41G mutation is important for the DNA-binding properties of the V47R D41G Oct-2 protein. This mutant protein has a selectivity ratio (OCTA/ A7G) of 13. In contrast, the wild-type protein has a selectivity ratio of Ͼ100. The V47R N51R double mutant exhibited a 3-fold higher affinity for the A7G site (K d ϭ 30 nM) than the V47R D41G double mutant. Also, it bound less well to the octamer element than V47R D41G and displayed a selectivity ratio of 1. We also assessed the consequence of combining the three mutations, V47R, N51R and D41G, to see if this would further increase affinity for the A7G site. The triple mutant V47R N51R D41G did not have higher affinity for A7G than V47R N51R ( Figure 3A) . We examined the specificity of these proteins by measuring affinity for other severe octamer mutations. The V47R D41G and V47R N51R Oct-2 mutant proteins did not bind the A6C and A5C octamer mutant sites with higher affinity (data not shown). Further- more, these mutant proteins do not have a general increase in non-specific binding affinity for DNA, because they do not recognize unrelated sites (see below; Figure 4A ).
Altered specificity Oct-2 proteins rescue an A7G mutant Ig promoter in vivo
For functional analysis, we used a β-globin reporter construct driven by an Ig promoter (see Materials and methods). The promoter was from the kappa light chain gene of the myeloma, MOPC41 (Bergman et al., 1984) . This promoter (Vκ) contains an octamer element 45 bp upstream of the TATA box, and is preferentially active in B cells. The reporter construct contains an SV40 enhancer downstream of the β-globin gene, since the enhancerless construct has very weak activity. The A7G mutation was introduced into this Vκ promoter (Vκ*) and assayed by transient transfection into the B cell line A20.1. Accurately initiated transcripts (AIT) from wild-type or mutant Vκ promoters were quantitated using ribonuclease protection 7109 assays after normalizing to transcripts from a reference construct (REF) . All measurements of promoter activity represent an average of at least four independent experiments (see Materials and methods). The mutant promoter showed Ͼ10-fold reduced activity in B cells ( Figure 3B , lanes 1 and 2). Expression constructs encoding wild-type Oct-2, Oct-2 V47R D41G and Oct-2 V47R N51R were used to examine the ability of each protein to rescue the function of the mutant promoter. Expression of Oct-2 V47R N51R resulted in a 4.5-fold activation of the mutant promoter (lane 4) and Oct-2 V47R D41G in 2-fold activation (lane 5). The control construct expressing wildtype Oct-2 did not activate the Vκ* promoter (lane 3). Furthermore, the altered specificity Oct-2 proteins did not stimulate transcription non-specifically, as evidenced by uniform levels of transcripts from the co-introduced reference construct. Stronger activation by Oct-2 V47R N51R compared with Oct-2 V47R D41G is probably due to its higher affinity for the A7G site. The substantial and specific restoration of mutant promoter activity by Oct-2 V47R N51R provides the first direct demonstration of Oct-2Јs ability to regulate the activity of an Ig gene promoter in B cells. Furthermore, this approach permits an unambiguous assay of exogenously introduced Oct-2 in B cells without the results being obscured by the activities of endogenous Oct-2 and Oct-1.
Oct-2 and Oct-1 are redundant activators of immunoglobulin promoters in B cells
Given the above results, the POU domain V47R N51R (RR) mutation could be used to compare the ability of Oct-2 and Oct-1 to rescue the activity of various octamerdependent promoters (Figure 1 ). The RR mutation was engineered into hemagglutinin (HA) epitope-tagged fulllength Oct-2 and Oct-1 cDNAs. Epitope tagging was done to permit an accurate comparison of the relative levels of expression of the two activators in the transfected cells. As expected, the RR mutation altered the binding properties of Oct-1 in an identical manner to Oct-2 ( Figure 4A ). Both Oct-1RR and Oct-2RR mutant proteins have selectivity ratios (OCTA/A7G) of 1 and bind the A7G site with 12-fold higher affinity than their wild-type counterparts. Furthermore, neither of the two proteins bind detectably to a non-specific DNA probe (λB).
The wild-type and altered specificity mutant versions of both proteins were tested for their ability to activate the Vκ* Ig promoter in B cells ( Figure 4B ). Transient transfections were performed in the B cell line MPC11, because its higher transfectability permitted detection of transiently expressed proteins by Western blotting. Both Oct-1RR and Oct-2RR altered specificity mutants substantially restored activity of the mutant Vκ* promoter, 12-and 15-fold respectively ( Figure 4B , lanes 4 and 6). In contrast, expression of wild-type Oct-1 or Oct-2 showed a very low degree of activation, probably mediated by residual DNA binding (lanes 3 and 5). Similar results were obtained in the B cell line A20.1 (data not shown).
Immunoglobulin heavy chain promoters contain an octamer element in the opposite orientation to that of light chain promoters. To assess the ability of Oct-1 and Oct-2 to function from this context, we also made the A7G mutation in a V H promoter and tested for rescue of promoter activity with the altered specificity mutants. Both Oct-1RR and Oct-2RR were able to restore significant activity to the A7G mutant V H promoter (see below, Figure  7A ). These experiments provide the first demonstration that Oct-2 and Oct-1 are functionally redundant in regulating Ig gene promoters in B cells.
Both Oct-2 and Oct-1 can regulate the activity of a histone H2B promoter in B cells
We next wanted to test if Oct-1 and Oct-2 could similarly regulate the activity of an octamer-dependent, but noncell type-specific promoter. The histone H2B promoter is ubiquitously active and has been shown previously to contain a functionally critical octamer element (Fletcher et al., 1987) . For this analysis, we made use of a β-globin reporter construct driven by a histone H2B promoter in place of the Ig promoter. The octamer element in this promoter is 8 bp upstream of the TATA box (Wang et al., 1996) . The wild-type construct (H2B) or a mutant version containing the A7G mutation in the octamer element (H2B*) were transfected into MPC11 B cells along with expression plasmids encoding the Oct-1 or Oct-2 altered specificity proteins. The A7G mutation caused a significant reduction in accurately initiated transcripts from the H2B promoter (6-fold, Figure 4C, lanes 1 and 2) . Interestingly, both Oct-1RR and Oct-2RR rescued the activity of the mutant H2B promoter, 4-and 5-fold respectively ( Figure  4C, lanes 4 and 6) . Control transfections using wild-type Oct-1 and Oct-2 expression vectors exhibited a low degree of activation (2-fold, Figure 4C, lanes 3 and 5) . Thus, while Oct-2 is expressed in a cell type-restricted manner, it, like Oct-1, is capable of activating a housekeeping gene promoter in B cells. Figure 4D shows the levels of epitope-tagged Oct-1 and Oct-2 proteins in the transiently transfected B cells. Under conditions using equivalent amounts of expression vectors (10 μg), the Oct-1 and Oct-1RR proteins were expressed at 5-fold higher levels than Oct-2 and Oct-2RR. It should be noted that the RR mutation does not affect the stability of either Oct-1 or Oct-2. We subsequently determined, by titrating various amounts of expression vectors, that 3 μg of Oct-1/Oct-1RR expression vectors and 10 μg of Oct-2/Oct-2RR expression vectors result in equivalent levels of expression of the four proteins (data not shown). Under these conditions, Oct-2RR activates Ig and H2B promoters 2-fold better than Oct-1RR (see below, Figure 6 ).
Efficient activation of Ig promoters in non-B cells requires OCA-B
A B cell-specific co-activator designated OCA-B/Bob1/ OBF-1 has been described as a key regulator of Ig gene transcription (Gstaiger et al., 1995; Luo et al., 1995; Strubin et al., 1995) . OCA-B activates Ig promoters via protein-protein interactions with the POU domains of promoter-bound Oct-1 or Oct-2. To compare the relative potencies of Oct-1 and Oct-2 in activating Ig promoters in the absence or presence of OCA-B, we performed the experiments described below.
Wild-type and mutant Vκ-β-globin reporter constructs were transiently transfected into HeLa cells along with the indicated expression constructs ( Figure 5A ). These cells express endogenous Oct-1 but not Oct-2 or OCA-B. As has been reported by others, the MOPC41 Vκ promoter has detectable activity in non-B cells (Kemler et al., 1991) . This activity is octamer and Oct-1 dependent, as it is reduced significantly by the A7G mutation ( Figure  5A, lanes 1 and 2) . Expression of Oct-1RR and Oct-2RR activated the mutant Ig promoter comparably in the absence of OCA-B (4-fold, lanes 4 and 6). OCA-B did not activate the Vκ* by itself (lane 3). However, coexpression of OCA-B with Oct-1RR or Oct-2RR further stimulated transcription (10-fold above the basal level, lanes 5 and 7). Neither wild-type Oct-1 nor Oct-2 significantly activated Vκ* (data not shown). Western blot analysis of the transiently expressed proteins showed that Oct-1 and Oct-1RR were at 5-fold higher levels than Oct-2 and Oct-2RR ( Figure 5B ). Under conditions of equivalent expression of Oct-1RR and Oct-2RR (reduced amounts of Oct-1RR expression plasmid), Oct-2RR activates the Ig promoter 3-fold better than Oct-1RR (data not shown). These results are similar to those obtained in the transfections of MPC11 B cells (Figure 6 ). Furthermore, they demonstrate that the RR mutation in the POU domain does not perturb the interaction with OCA-B. The ability of the RR POU domain to interact with OCA-B has been verified by performing gel-shift assays (data not shown). Therefore, by expressing the mutant octamer-binding proteins and wild-type OCA-B, we have reconstituted the components regulating Ig promoter activity without being hampered by endogenous Oct-1.
POU domain-mediated rescue of immunoglobulin and histone promoters
Despite the fact that Oct-1 and Oct-2 have related DNAbinding domains, overall these two proteins are structurally quite different. Intriguingly, we have demonstrated that they function as redundant activators of Ig and histone H2B promoters. The structural basis of this redundancy may reside in the two proteins utilizing distinct types of activation domains. Alternatively, the redundancy may be the result of the transcriptional activation properties of the conserved POU domain. To examine this issue, we compared the ability of the altered specificity full-length proteins with that of their POU domain counterparts to activate the Vκ* and H2B* promoters. Both altered specificity POU domains were able to restore activity (12-to 15-fold) of the Vκ* promoter significantly in MPC11 B cells ( Figure 6A, lanes 5 and 7) . This level of restoration is similar to that seen with the corresponding full-length proteins (lanes 2 and 3). Importantly wild-type POU domains did not activate the mutant promoter (lanes 4 and 6). It should be noted that the POU domain constructs were HA-tagged like their wild-type counterparts, and were expressed comparably with each other but at higher levels than the full-length proteins (data not shown). Similar results were obtained with the histone H2B promoter. However, in this case, the overall level of activation Figure 4B . All expression plasmids were used at 10 μg, with the exception of Oct-1RR, 3 μg. Both the full-length and POU domain proteins were tagged with the HA epitope to enable detection. (B) Rescue of mutant histone H2B promoter activity by altered specificity POU domains. Analyses were performed as described in (A).
with the altered specificity derivatives was somewhat lower (5-to 8-fold above basal levels, Figure 6B) . Therefore, the basis of functional redundancy of these two related activators resides in their conserved DNA-binding POU domain.
Ig enhancers dictate the relative potency of Oct-1 versus Oct-2 from Ig gene promoters
In the experiments described thus far, we have used a downstream SV40 enhancer in conjunction with both cell type-specific and ubiquitously active promoters. This was necessary because the activities of enhancerless wild-type promoter constructs were too weak to be detected reliably by RNase protection assays. The SV40 enhancer was used because it has been shown to act in conjunction with a variety of heterologous promoters and in numerous cell types. We next used the altered specificity mutants to examine the activities of Oct-1 and Oct-2 from Ig promoters in concert with their cognate enhancers from the Ig loci. The heavy chain intron enhancer (IE H ) is active throughout various stages of B cell development and has also been shown to be important for V(D)J recombination (Serwe and Sablitzky, 1993; Zou et al., 1993) . The Ig heavy chain locus contains an additional potent enhancer downstream of the Cα constant gene segments (3ЈE H ). This enhancer preferentially functions in activated B cells and plasmacytes (Pettersson et al., 1990; Lieberson et al., 1995) . A series of β-globin reporter constructs were generated in which the wild-type (V H ) or A7G mutant (V H *) promoters were linked to either the heavy chain intronic or 3Ј-enhancers, or the SV40 enhancer. Each of these enhancers was positioned downstream of the β-globin reporter gene. The mutant promoter constructs were co-transfected with expression vectors encoding the altered specificity Oct-1 or Oct-2 proteins. In these transfections, the amounts of the two expression vectors were adjusted so as to express equivalent amounts of the two altered specificity derivatives (3 μg of Oct-1RR and 10 μg of Oct-2RR expression plasmid). Results of these transient transfection analyses are shown in Figure 7A . An A7G mutation in the octamer element drastically reduced the activity of reporter gene expression when the V H promoter was coupled to any of the three enhancers ( Figure 7A , lanes 1 and 2, 5 and 6, 9 and 10). As seen previously with the Vκ* and H2B* promoters, both Oct-1RR and Oct-2RR could activate transcription from the V H * promoter in conjunction with three distinct enhancers. However, when expressed at equivalent levels, Oct-1RR was a 2-to 3-fold more potent activator than Oct-2RR when functioning from a V H * promoter coupled to either of the heavy chain enhancers. In contrast, Oct-2RR was a stronger activator than Oct-1RR from a V H * promoter coupled to the SV40 enhancer (2-fold). Similar results were obtained using the Vκ promoter in conjunction with cognate enhancers (intronic or 3Ј) from the kappa locus ( Figure 7B) . Thus, the enhancer to which an Ig promoter is coupled significantly influences the relative potency of promoter-bound Oct-1 versus Oct-2. To determine if the POU domain was sufficient to permit the more potent action of Oct-1 in these contexts, the activities of Oct-1RR POU and Oct-2RR POU were assayed using the Vκ*-3ЈEκ reporter construct. Unlike the full-length proteins, both altered specificity POU domains stimulated transcription equivalently ( Figure 7C) . Therefore, the more potent activity of Oct-1 from Ig promoters in conjunction with Ig enhancers is dependent on a region external to the POU domain. To our knowledge, this is the first demonstration of enhancers dictating the relative potencies of related activators functioning from the same site at a promoter.
Discussion

Regulation of Ig gene transcription by Oct-1 and Oct-2 in B lymphocytes
The identical binding properties but differing distributions of Oct-1 and Oct-2 led to the initial idea that Oct-1, being ubiquitously expressed, regulates the expression of octamer-dependent housekeeping genes, whereas Oct-2 regulates transcription of Ig genes through functionally critical octamer elements in their promoters (Schaffner, 1989) . This model was disproved by gene targeting of the oct-2 locus in mice and somatic B cells. Ig transcription was shown to occur at wild-type levels in oct-2 -/-pre-B and B cells (Corcoran et al., 1993; Feldhaus et al., 1993) . However, gene targeting experiments were unable to distinguish between redundancy and selectivity of these activators in regulating Ig genes. Results from the genetic studies, along with the discovery of the B cell-specific co-activator OCA-B, led to a revised view of the role of these activators. According to this model, OCA-B promotes B cell-specific transcription of Ig genes by interacting with either Oct-1 or Oct-2 (Luo et al., 1995) .
We wanted to address whether Oct-1 and Oct-2 are redundant or selective activators of Ig genes in B cells. Using equivalent Oct-1 and Oct-2 altered specificity mutants, we show that either factor can specifically promote transcription from Ig gene promoters in B cells. This represents the first direct demonstration of functional redundancy of these two transcriptional activators with respect to Ig promoters in the physiologically relevant context. Interestingly, Oct-1 is shown to be the more potent activator from an Ig promoter in conjunction with cognate Ig gene enhancers in B cells. This result provides molecular evidence that Oct-1 may be the critical regulator of Ig gene transcription during B cell development. Consistent with this view, developing B lineage cells express high levels of Oct-1, but significantly lower levels of Oct-2 (Miller et al., 1991) . The levels of OCA-B during early B cell development have not been reported. Furthermore, OCA-B-deficient mice show no impairment of Ig gene expression during B cell development (Kim et al., 1996; Schubart et al., 1996) . Therefore, the basal levels of Ig gene transcription seen during the antigen-independent phase of B cell development may be regulated predominantly by Oct-1. Activation and terminal differentiation of B lymphocytes induced by antigen encounter result in a large increase in transcription of Ig genes. Such cells contain high levels of both Oct-2 and OCA-B in addition to Oct-1. The induced state of Ig gene transcription may be dependent on the overall concentration of Oct-1 and Oct-2, as well as the co-activator OCA-B. The former could effect increased occupancy of Ig promoters and the latter increased transcriptional efficiency. In this regard, oct-2 null mice, as well as scid mice reconstituted with oct-2 -/-fetal liver progenitors, do have significantly reduced serum Ig levels (Corcoran et al., 1993; Corcoran and Karvelas, 1994) . Whereas this reduction has been attributed solely to a B cell proliferative defect upon antigen or lipopolysaccharide-mediated activation, it may be due additionally to the inability to transcribe Ig genes Figure 4B . The following amounts of expression vectors were used: Oct-1RR (3 μg), Oct-2RR (10 μg), Oct-1RR POU (3 μg) and Oct-2RR POU (3 μg).
optimally due to a reduction in the total level of octamer binding activators.
It has been proposed that Oct-1 regulates transcription of the housekeeping genes encoding histone H2B and U2 and U6 snRNAs (Fletcher et al., 1987) . Using altered specificity mutants, we directly compared the ability of Oct-1 and Oct-2 to regulate the activity of a histone H2B promoter in B cells. We demonstrate that both activators can regulate the activity of this non-cell-type-specific promoter. Although Oct-2 is clearly dispensible for H2B transcription, since it is not expressed in many cell types, its ability to function from this and other housekeeping gene promoters may be important during B cell activation. Antigen-driven activation of B lymphocytes results in extensive proliferation and high level expression of Ig genes. Therefore, there is a simultaneous demand for high level transcription of housekeeping genes, such as histone H2B and snRNAs, as well as Ig genes. It is possible that this demand represented the selection pressure to evolve the two related transcription factors, Oct-1 and Oct-2.
Transcriptional regulation by the POU domain
We show that the conserved DNA-binding POU domain of Oct-1 and Oct-2 can significantly promote transcription from Ig and histone H2B promoters. In the case of the Ig promoters, this activity may be explained by the ability of the POU domain to recruit the co-activator OCA-B (Luo et al., 1995) . Alternatively, the POU domain may have an activation potential that is not dependent on coactivators. In fact, Zwilling et al. (1994) have demonstrated that the POU domains of Oct-1 and Oct-2 physically interact with TATA box-binding protein. This interaction may facilitate pre-initiation complex formation directly. In this regard, the Oct-1 POU domain stimulates snRNA gene transcription by direct interactions with SNAP C (Mittal et al., 1996) . We show that the POU domain also activates transcription from the histone H2B promoter. The activity of this promoter is not dependent on OCA-B (Gstaiger et al., 1995; Luo et al., 1995) . Thus it is likely that the POU domain stimulates transcription by promoting formation of pre-initation complexes through specific interactions with general transcription factors. This intrinsic activity can be augmented through interactions with co-activators and linkage with activation domains.
Activator potency at a promoter is influenced by distal enhancers
Although Oct-1 and Oct-2 are functionally redundant as activators of Ig and H2B promoters in B cells, their relative potencies are different. In conjunction with a nonIg enhancer (SV40), Oct-2 is more potent relative to Oct-1 from these promoters. Interestingly, this relative potency is reversed when Ig enhancers from the heavy or light chain loci are used with their cognate Ig V H or Vκ promoters. The more potent activity of Oct-1 in such a context depends on an activation region external to the POU domain. These observations represent a unique demonstration that the relative potency of two related activators binding to the same site in the promoter can be significantly influenced by the nature of the distal enhancer. Thus, differential action of a family of related factors binding to the same regulatory site provides another mechanism for diversifying and specifying unique patterns of gene expression. Furthermore, this represents a powerful evolutionary strategy for extending the utility of the interaction between a conserved DNA-binding domain and its cognate site differentially to regulate gene activity.
The oct-2 -/-mice have a defect in expression of specific Ig isotypes (namely IgM, IgG1, IgG3 and IgG2B, but not IgA) (Corcoran and Karvelas, 1994) . Similarly, Kim et al. (1996) have demonstrated that OCA-B -/-B cells have a severe defect in expression of secondary Ig isotypes (all IgG subtypes, IgA and IgE) despite a normal ability to undergo switch recombination. They have suggested that closer apposition of the Ig V H promoter to the more distal 3Ј-enhancer, brought about by switching, may increase the dependency of the promoter on OCA-B. Our observation that the potency of Oct-1 and Oct-2 at a V H promoter can be influenced significantly by the nature of the distal enhancer provides evidence for this hypothesis. It also suggests the possibility that different switched IgH genes differ in their dependence on Oct-2 and/or OCA-B due to the relative configuration of downstream transcriptional enhancers.
DNA recognition of the A7G octamer by
Oct-2/Oct-1 altered specificity mutants To achieve increased affinity for the A7G mutant octamer site, at least two amino acid substitutions in the POU domain are necessary. In the case of the V47R N51R altered specificity mutant, both substitutions lie in the recognition helix of the POU homeodomain. However, in the V47R D41G mutant, one substitution lies in the POUspecific domain. Amino acid D41 is located in the unique extended turn between helices 2 and 3 of the POU-specific domain's helix-turn-helix motif. This residue has not previously been considered to be important for the binding of the Oct-1 POU domain to the octamer element in the crystallographic structure (Klemm et al., 1994) . Examination of the crystal structure reveals that this residue is only 4.4 Å away from the negatively charged phosphate residue between G4 and T5 of the octamer ( Figure 2B ). The charge repulsion due to this proximity is removed by substitution of the negatively charged aspartic acid residue with a neutral glycine. This may result in an increased affinity for weaker binding sites where the energetic contribution of this interaction becomes relatively important in combination with a favorable change at Val47.
Isolation of altered specificity mutants by expression screening
Given that a widely used method for the cloning of transcription factors involves screening a λgt11 cDNA expression library with a radiolabeled binding site, it was appealing to modify this approach so as to extend it to the isolation of altered DNA-binding specificity mutants (Singh, 1993) . The simplicity and power of this method made it an attractive choice in relation to other strategies for the isolation of altered specificity mutants (Strubin and Struhl, 1992; Hill et al., 1993; Rebar and Pabo, 1994) . We demonstrate the utility of this approach by successfully screening two distinct altered specificity Oct-2 mutants (D41G V47R and V47R N51R, Figure 2C and D). The V47R N51R was isolated initially using a plasmid-based expression screening strategy in the context of an Oct-1 POU domain fusion protein (Pomerantz and Sharp, 1994) . Expression screening for altered specificity mutants provides several advantages over genetic screens in Escherichia coli or yeast. First of all it directly assays DNA binding, rather than transcriptional activation or repression. Secondly, it is much simpler to set up. This is especially true for transcription factors that have been isolated originally by screening λgt11 cDNA expression libraries, such as Oct-1/Oct-2/Pit-1 (POU family), Ets-1/ PU.1 (Ets family), E12/HTF-4/TEF-1 (bHLH family), IRF-1/ICSBP/Pip (IRF family), MBP-1/WZF-1 (Zn finger family) and EBP/CREB (leucine zipper family) (reviewed in Singh, 1993) .
The general utility and power of the expression screening approach can be exploited more fully in cases where no high resolution structure nor detailed model of the protein-DNA complex exists, and therefore there is no information to suggest which amino acids make basespecific contacts. In combination with a codon-based mutagenesis strategy (Glaser et al., 1992; Cormack and Struhl, 1993) , one could readily employ expression screening to scan single and double amino acid substitutions across a large protein segment in tracts of 20 amino acids. All single amino acid substitutions across a 20 amino acid segment can be screened in a library of~3000 clones (Cormack and Struhl, 1993) . Approximately 30% of such a library would also contain double amino acid substitutions. Expression screening conveniently permits analysis of 10 7 clones. Thus, the approach promises to be a useful method for isolating altered specificity mutants for analysis of transcription factor function as well as in identifying amino acids involved in DNA recognition.
A paradigm for using altered specificity mutants to analyze related transcription factors
Higher eukaryotes express a large number of related transcription factors with overlapping expression patterns. As elaborated in the Introduction, this makes it difficult to dissect the transcriptional regulatory activities of different co-expressed members of such families. This study demonstrates that altered specificity mutant proteins represent powerful tools to examine directly the issues of redundancy versus promoter selectivity among members of a family of related transcription factors. Furthermore, these mutant proteins can be used to explore the molecular basis of these differences in vivo. Altered specificity mutant transcription factors have been used previously to establish functionally important interactions with target sequences in vivo (Schier and Gehring, 1992; Hill et al., 1993; Klein and Struhl, 1994) . However, our study represents the first example in which such mutants are used to distinguish between regulatory activities of related factors.
Materials and methods
Engineering a λgt11 phage library of Oct-2 DNA-binding domain mutants A 1.1 kb partial Oct-2 cDNA from λgt11 3-1 was subcloned into pBSt to generate pKSOct-2(1.1). The λgt11 3-1 phage is denoted as λOct-2 in the text. The cDNA insert encodes the POU domain and a C-terminal segment of Oct-2A. Codons encoding Val47, Cys50 and Asn51 of the POU homeodomain were randomized individually using sequence overlap extension PCR. Representative clones were sequenced to verify the efficacy and absence of biases in the mutagenesis.
Altered specificity mutants: Oct-1 versus Oct-2
Mutant cDNAs were religated into λgt11 phage arms and packaged using a Gigapack Gold kit (Stratagene). Recombinant phage resulting from mutagenesis of individual codons were pooled for expression screening. The λOct-2 V47R N51R mutant phage was constructed as follows: an EagI-PstI fragment of pKSOct-2(1.1) was replaced by the corresponding fragment from pHA-Oct-2RR(L); the 1.1 kb EcoRI fragment of the resulting construct was ligated into λgt11 arms and subsequently packaged to generate the phage.
Expression screening
Screening of λOct-2 phage and its mutant derivatives was performed using either a wild-type octamer trimer or an A7G mutant octamer trimer. Each probe consisted of a directly repeated array. The sequence of the monomeric wild-type oligonucleotide is given below (see Gelshift assays). Screening was performed as described by Singh (1993) . The A7G mutant probe was used to screen 30 000 recombinants in the λOct-2 mutant library. Anti-Oct-2 antibodies were used to screen the recombinant plaques and verify that the mutant clones were producing the same level of Oct-2 protein as the wild-type phage.
Oct-2 and Oct-1 expression constructs Full-length Oct-2 cDNA from pOEV1ϩ (Muller et al., 1988) was subcloned into pGEM4Z for in vitro expression. This plasmid was used to generate the mutants V47R, D41G, V47R D41G, V47R N51R and D41G V47R N51R. These wild-type and mutant Oct-2 cDNAs were subcloned into pcDNA3 for in vivo expression. For expressing HA epitope-tagged proteins, Oct-2 or Oct-1 cDNAs were subcloned into pcDNA3-HA (Brass et al., 1996) . This vector introduces the hemagglutinin nonapeptide (12CA5 epitope) at the N-terminus. pHA-Oct-2(L) and pHA-Oct-2RR(L) contain wild-type and Oct-2 mutant (V47R N51R) cDNAs respectively. pHA-Oct-2(S) and pHA-Oct-2RR(S) have a truncated 3Ј-untranslated region (3Ј-UTR; 60 nucleotides). They delete a 460 bp XbaI-BstEII fragment from the 3Ј-UTR of the Oct-2 cDNA. pHAOct-1 was generated by subcloning the Oct-1 cDNA insert from pCMVOct-1 into pcDNA3-HA (Voss et al., 1991) . In this construct, PCR was used to introduce coding sequence for 21 N-terminal amino acids missing in pCMV-Oct-1 (Das and Herr, 1993) . The POU domains of Oct-1 or Oct-2 were isolated by PCR using the following primers: ATGAGG-CGGCCGCGAGGAGCCCAGTGACCT, GTGGTCTAGATCATG-GGTTGATTCTTTTTTC for Oct-1 and TGGTGGCGGCCGCGAGG-AGCCCAGTGATCTG, CCCGTCTAGATCAGGGGTTGATGCGTT-TCTC for Oct-2. The PCR fragments were then subcloned into pcDNA3-HA. Control experiments with in vitro translated proteins showed that the tagged Oct-2 and Oct-1 derivatives were equally reactive with the anti-HA antibody.
Reporter constructs and other plasmids
The Vκ promoter construct is a derivative of Target-1 that was generated by replacing the minimal β-globin promoter (-43 to -10) with the MOPC41 Vκ promoter (-100 to ϩ25) as described by Feldhaus et al. (1993) . This construct contains an SV40 enhancer (E SV ) downstream of the β-globin gene. The V H and H2B promoter constructs were generated by substituting the Vκ promoter with, respectively, a V H promoter SalIXbaI fragment (-154 to ϩ57) and a H2B promoter (-102 to ϩ68) obtained by PCR from the clone mm616-1.4 with the following primers: TCGCTGGATCCGGCATTTTC and ACGCTGACTCTGCTGTAAATC (Grosschedl and Baltimore, 1985; Wang et al., 1996) . The Vκ*, V H * and H2B* reporter constructs contain an A7G mutation in the octamer element of the corresponding promoters. Accurately initiated transcripts from the wild-type and mutant kappa promoters were assayed using a riboprobe synthesized using pSKVκ41 (Feldhaus et al., 1993) . The templates used to synthesize the V H and H2B riboprobes were generated by replacing the Vκ promoter in pSKVκ41 with the V H and H2B promoters respectively. The V H -IE H and V H -3ЈE H constructs were made by replacing the SV40 enhancer in the V H promoter construct with an XbaI intron-enhancer and a StuI 3Ј-enhancer heavy chain fragment, respectively (Dariavach et al., 1991) . The Vκ-IEκ and Vκ-3ЈEκ constructs were made by replacing the SV40 enhancer in the Vκ construct, with the intron (AluI fragment) and 3Ј kappa (Sac-XbaI fragment) enhancers, respectively. Other plasmids used in this study have been described previously: pCATCH, pCatch-NLS-Bob1 (Gstaiger et al., 1995) , Target-1 and OVEC-Ref (Muller et al., 1988) .
In vitro transcription and translation
In vitro translations were performed using 1 μg of the indicated plasmid in 50 μl of TNT-coupled transcription/translation reaction (Promega) as per the manufacturer's instructions. [ 35 S]methionine-labeled proteins 7115 were resolved in a 10% SDS-polyacrylamide gel, dried and quantitated on a PhosphorImager system (Molecular Dynamics).
Gel-shift assays
Binding of Oct-2 and Oct-1 proteins was analyzed using a gel-shift assay with the following probe or its mutant derivatives: 5Ј-GAT-CCTTAATAATTTGCATACCCTCA-3Ј 3Ј-GAATTATTAAACGTATG-GGAGTCTAG-5Ј.
The octamer sequence and flanking base pairs are derived from the MOPC41 Vκ promoter. To test for non-specific binding, control λB sequence derived from an Ig lambda enhancer was used (Brass et al. 1996) . Complementary oligonucleotides were annealed and end labeled with [α-32 P]dATP and the Klenow fragment. Nuclear extracts were prepared as described by Singh et al. (1986) . Nuclear extract protein (20 μg) or in vitro translated protein (10-30 fmol) was incubated with 4 or 1 μg of poly(dIdC), respectively, and 5ϫ10 5 c.p.m. (6-20 fmol) of the octamer probe in 20 μl of binding buffer for 30 min at 25°C. The resulting complexes were resolved on a 6% native polyacrylamide gel using 1ϫ TGE buffer (Staudt et al., 1988) . Quantitation of protein-DNA complexes was performed using a PhosphorImager system (Molecular Dynamics). Relative affinity measurements represent an average of at least five independent binding experiments. Dissociation constants were determined using the following relationship, K d ϭ ( 
Western analysis
Protein samples were resolved in a 10% SDS-polyacrylamide gel and transferred to a Immobilon P membrane (Millipore). Blots were incubated with 1:3000 dilution of rabbit anti-Oct-2 antiserum and 1:5000 dilution of donkey anti-rabbit horseradish peroxidase (HRP) conjugate. The anti-HA (12CA5) mouse monoclonal antibody was used at 2 μg/ml with a rabbit anti-mouse Ig HRP secondary conjugate at 1:2500. Immunoreactive proteins were detected using the ECL system (Amersham).
Transient transfection analysis
All transfections were performed at least four times. MPC11 cells. Seventeen μg of total DNA were transfected per 5ϫ10 6 cells using a calcium phosphate protocol. This DNA included 3 or 10 μg of Oct-1 expression construct and 10 μg of the Oct-2 expression constructs pHA-Oct-2(S)/pHA-Oct-2RR(S), 5 μg of the reporter construct and 2 μg of the reference plasmid OVEC-Ref. The total amount of transfected DNA was kept constant in each transfection by including a compensating amount of the parent cytomegalovirus (CMV)-based expression vector pcDNA3. Total RNA was isolated 40-42 h after transfection. A20.1 cells. Thirty μg of total DNA were transfected per 10 7 cells using a DEAE-dextran-based protocol as described previously (Feldhaus et al., 1993) . This DNA included 20 μg of expression vector, 5 μg of reporter, 2 μg of reference construct OVEC-Ref and 3 μg of pBSt carrier DNA. pHA-Oct-2(L) and pHA-Oct-2RR(L) were used for expressing Oct-2 and its derivatives in this cell line. HeLa cells. Twenty-one μg of total DNA were transfected per 10 6 cells using a calcium phosphate protocol. This DNA included 1, 5 or 15 μg of Oct-2/1 expression construct, 4 μg of pBSt and 1 μg each of the reporter construct and the reference plasmid OVEC-Ref. The total amount of transfected DNA was kept constant in each transfection by including a compensating amount of the parent CMV-based expression vector pcDNA3. In transfection experiments involving OCA-B, 4 μg of pCATCH-NLS-Bob1 was used in place of pBSt and pCATCH used as the parent empty expression vector. pHA-Oct-2(L) and pHA-Oct-2RR(L) were used for expressing Oct-2 and its derivatives in this cell line. Total RNA was isolated 40-42 h after transfection.
RNA isolation and analysis
Total cellular RNA was isolated from transiently transfected cells using RNAzol B (Tel-Test). RNase protection analysis was performed using 10 μg of total RNA with the pSKVκ41 riboprobe, essentially as described previously (Miller et al., 1991) . Accurately initiated transcripts from the Vκ promoter constructs generate a 240 nucleotide protection product. Reference transcripts from OVEC-Ref produce a 158 nucleotide protection product.
